What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
The following is the science in plain English: AOD-9604 is based on part of the human growth hormone, specifically aimed at fat cells
Results that look dramatic in mice often translate to more modest outcomes in people
Always tell your doctor about all your current medicines, including any prescriptions, over-the-counter drugs, vitamins, and herbal products
Certificate CPD certificate on completion - this confirms online theory completion, not hands-on treatment competency